Procyrion Closes $57.7 Million in Series E Financing
Procyrion notes the funding will support the DRAIN-HF pivotal IDE trial evaluating the company’s Aortix pump, internal R&D programs to improve manufacturability, and commercialization preparation.
February 5, 2024